|
HY-112498-10mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-25mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-5mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-112498-50mg
|
MedChemexpress LLC
|
Cy3 NHS ester [CAS 1393363-07-9]
|
|
|
|
|
HY-118870-10mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-100mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-25mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-5mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-118870-50mg
|
MedChemexpress LLC
|
gamma-Globulins from human blood [CAS 9007-83-4]
|
|
COVID-19-anti-virus
|
|
|
HY-126360-1g
|
MedChemexpress LLC
|
Oxazolone [CAS 15646-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-126360-5g
|
MedChemexpress LLC
|
Oxazolone [CAS 15646-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-126360-500mg
|
MedChemexpress LLC
|
Oxazolone [CAS 15646-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-131326-100mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
|
HY-131326-25mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
|
HY-131326-250mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
|
HY-131326-50mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
|
HY-138200-10mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
|
HY-138200-25mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
|
HY-138200-5mg
|
MedChemexpress LLC
|
Cy5 maleimide [CAS 1437796-65-0]
|
|
|
|
|
HY-138632-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
|
HY-138633-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
